BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15255832)

  • 1. Aripiprazole-induced rabbit syndrome.
    Mendhekar DN
    Aust N Z J Psychiatry; 2004 Jul; 38(7):561. PubMed ID: 15255832
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole-induced extrapyramidal side effects in a patient with schizoaffective disorder.
    Ziegenbein M; Sieberer M; Calliess IT; Kropp S
    Aust N Z J Psychiatry; 2006 Feb; 40(2):194-5. PubMed ID: 16476141
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole's receptor pharmacology and extrapyramidal side effects.
    Poyurovsky M; Weizman R; Weizman A
    Am J Psychiatry; 2008 Mar; 165(3):398; author reply 398-9. PubMed ID: 18316435
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole and extrapyramidal symptoms.
    Lindsey RL; Kaplan D; Koliatsos V; Walters JK; Sandson NB
    J Am Acad Child Adolesc Psychiatry; 2003 Nov; 42(11):1268-9. PubMed ID: 14566162
    [No Abstract]   [Full Text] [Related]  

  • 6. Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome.
    Rizzo R; Gulisano M; Calì PV
    Eur Child Adolesc Psychiatry; 2012 Oct; 21(10):591-2. PubMed ID: 22692815
    [No Abstract]   [Full Text] [Related]  

  • 7. Case series: extrapyramidal symptoms associated with use of aripiprazole in older adults.
    Sweeney EB; Lawlor BA
    Int J Geriatr Psychiatry; 2013 Nov; 28(11):1208-10. PubMed ID: 24101361
    [No Abstract]   [Full Text] [Related]  

  • 8. Hiccups associated with switching from olanzapine to aripiprazole in a patient with paranoid schizophrenia.
    Hori H; Nakamura J
    Clin Neuropharmacol; 2014; 37(3):88-9. PubMed ID: 24824665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study.
    Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
    Am J Addict; 2011; 20(2):179-80. PubMed ID: 21314764
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperprolactinemia with aripiprazole: understanding the paradox.
    Saraf G; Behere RV; Venkatasubramanian G; Rao NP; Varambally S; Gangadhar BN
    Am J Ther; 2014; 21(3):e80-1. PubMed ID: 22357167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
    Crismon ML; DeLeon A; Miller AL
    Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
    [No Abstract]   [Full Text] [Related]  

  • 12. The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.
    Citrome L
    Int J Clin Pract; 2015 Nov; 69(11):1211-20. PubMed ID: 26477545
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of Aripiprazole and extra pyramidal side effects.
    Salmoiraghi A; Odiyoor M
    J Psychopharmacol; 2006 Jul; 20(4):592-3. PubMed ID: 16401661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
    Raja M
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):107-10. PubMed ID: 16487453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial dopamine agonists in schizophrenia.
    Launer M
    Hosp Med; 2005 May; 66(5):300-3. PubMed ID: 15920862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
    Evcimen YA; Evcimen H; Holland J
    Am J Psychiatry; 2007 Sep; 164(9):1436-7. PubMed ID: 17728431
    [No Abstract]   [Full Text] [Related]  

  • 17. Agitation associated with aripiprazole initiation.
    Lea JW; Stoner SC; Lafollette J
    Pharmacotherapy; 2007 Sep; 27(9):1339-42. PubMed ID: 17723088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
    Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patient.
    Gonidakis F; Ploubidis D; Papadimitriou G
    Schizophr Res; 2008 Aug; 103(1-3):341-2. PubMed ID: 18262773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.